HCW Biologics Inc. short interest in 2023
In 2023, HCW Biologics Inc.'s disclosed short interest ran from 0.07% of shares outstanding on 13 Jan 2023 to 0.02% on 29 Dec 2023, a change of -0.05 percentage points. The year's high was 0.10% on 30 Jun 2023 and its low 0.02% on 31 Oct 2023, averaging 0.06% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.77 days on 28 Apr 2023. Full history: HCW Biologics Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.07% (13 Jan 2023)
- End of year
- 0.02% (29 Dec 2023)
- Change
- -0.05 pp
- High
- 0.10% (30 Jun 2023)
- Low
- 0.02% (31 Oct 2023)
- Average
- 0.06%
- Highest days to cover
- 4.77 (28 Apr 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.07% | 1.00 | |
| 15 Feb 2023 | 0.05% | 1.00 | |
| 28 Feb 2023 | 0.08% | 1.07 | |
| 15 Mar 2023 | 0.06% | 1.07 | |
| 31 Mar 2023 | 0.07% | 2.50 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 0.08% | 1.71 | |
| 28 Apr 2023 | 0.08% | 4.77 | |
| 15 May 2023 | 0.04% | 1.20 | 10-Q filed, results (8-K) |
| 31 May 2023 | 0.04% | 1.00 | |
| 15 Jun 2023 | 0.07% | 1.00 | |
| 30 Jun 2023 | 0.10% | 2.37 | |
| 14 Jul 2023 | 0.07% | 4.17 | |
| 31 Jul 2023 | 0.06% | 2.17 | |
| 15 Aug 2023 | 0.07% | 4.21 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 0.06% | 4.09 | |
| 15 Sep 2023 | 0.06% | 1.79 | |
| 29 Sep 2023 | 0.03% | 1.14 | |
| 13 Oct 2023 | 0.03% | 2.11 | |
| 31 Oct 2023 | 0.02% | 1.69 | |
| 15 Nov 2023 | 0.06% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 0.06% | 1.57 | |
| 15 Dec 2023 | 0.03% | 1.00 | |
| 29 Dec 2023 | 0.02% | 1.00 |
See also: HCW Biologics Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.